|
Continuing education credits for the CVP Vaccine Coordinator Training will be paused for the month of June while we close out the state fiscal year.
Providers may still continue to take modules 1-9 as needed. If continuing education credit is desired (for nurses, medical assistants and pharmacists/pharmacy techs), providers can complete Module 10 in July when that module is reactivated.
Thank you for your understanding.
Vaccine choice is occurring from Wednesday June 4th through Friday June 20th.
During this time providers can fill out the Vaccine Choice form to request a change in the brand of vaccine they receive for vaccines with more than one brand available.
Please use the following link to access the form to request changes. You only need to submit a form if you are requesting a change. If you are keeping the same vaccines no form is needed.
Vaccine Choice Worksheet (wa.gov)
Submit forms either by e-mail to WAChildhoodVaccines@doh.wa.gov or by fax to 360-236-3811.
If you have any questions please contact Jacki Stockdale at jacki.stockdale@doh.wa.gov
Some vaccine choice highlights:
- Due to the Men B component and the inability to interchange the Men B vaccine, Penbraya will be available only to those that receive Trumenba as their Men B product.
- With anticipation of Penmenvy approval later this summer, it is notated that this vaccine will be available to those that receive Bexsero as their Men B vaccine. Once Penmenvy is available it will be added to the order sets that contain Bexsero.
- If a vaccine is not on the Vaccine Choice Worksheet as an option, it indicates that there is only one brand for that vaccine and is automatically on all order sets.*
- *Exceptions: Mpox is only available through special request. Seasonal vaccines have their own order set.
Last month, the Washington Vaccine Association (WVA) notified providers and payers of the upcoming changes to the Vaccine Assessment Grid, which will be effective between July 1, 2025, through June 30, 2026.
The Grid lists vaccines and immunizations, along with their CPT codes, that are included in Childhood Vaccination Program (CVP) and for which the dosage-based assessment (DBA) process is required. This applies to healthcare providers, insurance companies, and third-party administrators (TPAs). The Grid acts like a fee schedule. Providers are required to submit the DBA with the correct Grid amount based upon date of service when CVP supplied vaccines are administered to patients with private/commercial insurance. Properly submitted DBAs ensure that adequate funds are available to support the state’s continued purchase of pediatric vaccines and immunizations for Washington children under age 19.
The Grid is posted to the WVA’s website in both PDF and Excel format. For more information on the billing process, please review the WVA Provider Billing Guide. Should you have any other questions for the WVA, please contact us at info@wavaccine.org.
If you are a Washington state health care professional who offers HPV vaccine, we invite you to participate in a brief survey about your experiences recommending the HPV vaccine. Your insights will help shape future training programs, quality improvement initiatives, and the development of essential resources.
Survey Here
Your input will make a difference!
Deadline: June 20, 2025
Invitations to complete the CVP Provider Satisfaction Survey in REDCap were sent to primary and back-up vaccine coordinators on June 2nd. The survey will remain open for 3 weeks. The data we collect helps us to improve customer service and provider support. If you have not already done so, we would love to get your feedback!
Training slides for the May 29th Childhood Vaccine Program (CVP) How to Reduce Vaccine Waste Webinar are now available. A recording of this presentation will be posted on our Training webpage under the Recorded Webinars heading by the end of the week.
If you have any questions, please contact us at WAChildhoodVaccines@doh.wa.gov.
The foldable, pocket-sized laminated schedules are back by popular demand and now available to order. There are limited supplies, so get your order in as soon as possible. Please note that there were recent changes to COVID-19 vaccine recommendations, and there may be future changes not reflected on these hard copy schedules. Please go to CDC's Child and Adolescent Immunization Schedule by Age for the most current recommendations.
Ordering Instructions
Order Free Immunization Materials
Order free immunization materials online, by email, or by fax. Faxed orders will only be accepted if you don't have Internet access. Ordering materials online is the easiest and fastest way to place your order. If you don't have Internet access, please e-mail immunematerials@doh.wa.gov or call 360-236-3481 for an order form and information on how to place your order by fax.
Order materials online
Order materials by e-mail
- Send an e-mail to ImmuneMaterials@doh.wa.gov. Be sure to include:
- The material(s) you want to order.
- The quantity of each material.
- Your name, address, and phone number.
Children’s Hospital of Philadelphia (CHOP) created multiple vaccines and disease infographics for children and adults that can be printed or ordered from CHOP for your clinics.
The Vaccines During Pregnancy: Timing and Notes About Protection (infographic): PDF | PNG is also available describing which vaccines are recommended during pregnancy. Prenatal care providers may find the Making Vaccine Decisions During Pregnancy: What to Know article helpful when offering vaccine recommendations to their pregnant patients.
Immunize.org recently updated its Ask the Experts: Vaccine Recommendations regarding acceptable injection volumes, especially with the need to administer nirsevimab (Beyfortus) 1-mL injection volume to deliver a 100-mg dose. Infants who need nirsevimab may also need routine vaccinations at the same visit. The Q&A is copied below.
Q: Is there a strict limit to the volume of vaccine and/or monoclonal antibody that can be administered in a single limb (deltoid or thigh) at one immunization visit? Someone told me recently not to administer more than 1 mL of volume into an infant’s thigh.
A: This question has arisen more frequently since the introduction of the RSV preventive antibody, nirsevimab (Beyfortus, Sanofi), which has an injection volume of 1 mL for infants younger than 8 months who weigh 5 kg or more at the time of immunization. High risk children entering their second RSV season require a Beyfortus dose volume of 2 mL. Beyfortus is often administered at a routine visit when other infant immunizations are due.
There is no specific guidance to not exceed 1 mL in one muscle. In fact, there is no clear standard of practice and reference texts vary in guidance. Facilities or health systems may have medication policies/procedures that outline guidance for their staff. Professional judgement is needed when administering intramuscular medications or immunizations to people, including children, because muscle size varies from person to person.
CDC experts suggest a range of volume, depending upon the muscle injected. For the deltoid, the typical volume injected is 0.5 mL (maximum: 2 mL). For the vastus lateralis (the thigh), the typical volume that may be injected is 1–4 mL (maximum: 5 mL). Infants and toddlers fall at the lower end of these ranges, whereas adolescents and adults generally fall on the higher end of the range.
If more than 1 mL of volume needs to be injected into the thigh, that can be done while staying well within the acceptable range. Use of combination vaccines, when indicated and available, can decrease injection volume.
The Institute for Vaccine Safety - Talking with Patients and Parents about Vaccines online module is an interactive and self-paced program that offers Continuing Medical Education (CME) for providers and pharmacists. It’s a great resource to improve the efficiency and effectiveness of clinical vaccine discussions with patients. The module discusses using the effective “Presumptive Approach” when introducing the topic of vaccines and presents the “5-Step Strategy” to improve informed vaccine decision-making among vaccine hesitant parents.
|
